Podcast: solo founder used Claude to design a drug, then sold the company to Anthropic
gabepgomes · x · 2026-11-21
A conversation with Shelby Newsad, partner at Compound VC leading biotech and healthtech investing, explores whether one person can build a biotech company.
- Mithril Medicine's founder—whose company was acquired by Anthropic—used Claude to help design a drug and outsource experiments, while retaining judgment over where his own expertise mattered and which bills founders still must pay.
- Other topics: why drug companies keep chasing the same targets, when selling data to an AI lab means selling your competitive edge, and how a protein-sweetened soda relates to inventing entirely new flavors.
More from Companies & People
- AppSumo cut from 140 to 20 people: Noah Kagan shares his 6 rules for zero-person companies — vaibhavbetter · 2026-11-21
- Viral joke: Jensen Huang threatened to force employees to buy ETH if they missed deadlines — econoar · 2026-11-21
- Beyond Claude wrappers: real opportunity is data-driven video editing for creators — ayushtweetshere · 2026-11-21
- Palmer Luckey: I've never had an original idea — everything comes from 70-year-old sci-fi — CatAstro_Piyush · 2026-11-21
- Behind 'plane bench': the overnight trip to demo Inkling 2 Mini offline mid-flight — simonguozirui · 2026-11-21
- Ex-Google Gemini/Veo PM, now at Meta, invites Chennai AI builders to meet up — realmadhuguru · 2026-11-21